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Preeclampsia
Blood Pressure Change in Normotensive, Gestational
Hypertensive, Preeclamptic, and Essential
Hypertensive Pregnancies
Corrie Macdonald-Wallis, Debbie A. Lawlor, Abigail Fraser, Margaret May,
Scott M. Nelson, Kate Tilling
See Editorial Commentary, pp 1099–1100
Abstract—We compared patterns of blood pressure (BP) change among normotensive women, women who developed
gestational hypertension or preeclampsia, and women who had essential hypertension to examine how distinct these
conditions are and whether rates of BP change may help to identify women at risk for hypertensive disorders. We used
antenatal clinic BP measurements (median, 14 per woman) of 13016 women from the Avon Longitudinal Study of
Parents and Children who had a singleton or twin live birth surviving until 1 year. Linear spline models were used
to describe changes in systolic and diastolic BPs in different periods of pregnancy (8–18, 18–30, 30–36, and 36
weeks’ gestation). Women who had essential hypertension and those who developed gestational hypertension or
preeclampsia had higher BP at 8 weeks’ gestation (baseline) compared with normotensive women. The decrease in BP
until 18 weeks was smaller in gestational hypertensive compared with normotensive pregnancies. BP rose more rapidly
from 18 weeks onward in gestational hypertensive and preeclamptic pregnancies and from 30 weeks onward in
essential hypertensive compared with normotensive pregnancies. Women who developed preeclampsia had a more
rapid increase in BP from 30 weeks onward than those who developed gestational hypertension or had essential
hypertension. Our findings indicate notable patterns of BP change that distinguish women with essential
hypertension, gestational hypertension, and preeclampsia from each other and from normotensive women, even from
early pregnancy. These distinct patterns may be useful for identifying women at risk of developing a hypertensive
disorder later in pregnancy. (Hypertension. 2012;59:1241-1248.) ● Online Data Supplement
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Hypertensive disorders of pregnancy (HDP), consisting ofgestational hypertension, preeclampsia, and essential
hypertension, affect 10% of pregnancies1 and are associ-
ated with maternal and perinatal mortality,2,3 small-for-
gestational-age infants, and preterm birth.1,4–6 Gestational
hypertension and preeclampsia are defined using blood pres-
sure (BP) thresholds after 20 weeks’ gestation, with the
additional criteria of proteinuria for preeclampsia.7
In normal pregnancy, BP initially decreases until 18 to 20
weeks’ gestation and then rises until delivery,8–11 and studies
have indicated that higher BP prepregnancy12,13 and in the
first trimester14–16 are associated with increased risk of
developing gestational hypertension and preeclampsia. The
few studies that have assessed BP trajectories across gestation
in different HDP groups suggest that the relative change in
BP may provide additional indication of HDP risk relative to
a single BP measurement. However, these studies were
limited by their size (mostly N 1000), number of repeat
measurements available, or outdated definitions of HDP and
did not assess differences in rates of BP change between
groups in different periods of pregnancy.10,17–22 Comparing
changes in BP between gestational hypertensive and pre-
eclamptic pregnancies is useful for assessing the distinctness
of these conditions and whether the greater risk associated
with preeclampsia is attributable solely to its additional
systemic changes, indicated by proteinuria, or also attribut-
able to the severity of vascular problems, represented by
greater increases in BP.
Our study aims to investigate whether patterns of BP
change across pregnancy differ among normotensive women,
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those who have hypertension before pregnancy (referred to as
“essential hypertension” throughout the article, for ease of
reporting), and those who develop gestational hypertension or
preeclampsia in a large prospective cohort of women. Pre-
eclamptic pregnancies have a high risk of medically indicated
preterm delivery,23 particularly if maternal BP rises rapidly in
late gestation.24,25 We have, therefore, modeled BP change
jointly with time to delivery to adjust for the shorter gesta-
tional period in women who experienced greater rises in BP.
Methods
The Avon Longitudinal Study of Parents and Children is a prospec-
tive birth cohort study aiming to investigate the health and develop-
ment of children. The study has been described in full elsewhere26
and on the Web site www.bris.ac.uk/alspac. Pregnant women with
expected delivery dates between April 1, 1991, and December 31,
1992, living in Avon (United Kingdom) during their pregnancy were
eligible for recruitment. Data have been collected through question-
naires, research clinics, and linkage to routine health records. Ethical
approval for the study was obtained from the Avon Longitudinal
Study of Parents and Children Law and Ethics Committee and from
the National Health Service local ethics committee. In total, 14541
women were enrolled, 13796 had singleton or twin pregnancies
where the offspring were alive at 1 year, and 13578 of these women
had data abstracted from obstetric records. We excluded women who
had existing (N43) or gestational (N56) diabetes and women
who had a gestational period 44 weeks (N6), which left 13016
women with 1 BP measurement available for analysis.
All of the BP and urine dipstick proteinuria measurements taken
routinely as part of antenatal care by midwives, obstetricians, or
other relevant health professionals, such as general practitioners,
were abstracted from obstetric medical charts by 6 trained research
midwives. There was no between-midwife variation in mean values
of the data abstracted, and error rates were consistently 1% in
repeated data entry checks. These were single BP measurements
taken in the seated position using the appropriate cuff size, and
diastolic BP (DBP) was measured using Korotkoff phase V. There
was a median of 14 (interquartile range, 11–16) BP measurements
per woman. The gestational age at each visit was derived from the
date of measurement and the expected delivery date. A questionnaire
administered during pregnancy asked about previous hypertension.
Women who reported having been diagnosed previously with hyper-
tension outside of pregnancy and were aged 16 years at diagnosis
were considered to have essential hypertension. For women who did
not have essential hypertension, HDP was defined according to
International Society for the Study of Hypertension in Pregnancy
criteria,7 with gestational hypertension defined as systolic BP (SBP)
140 mmHg and/or DBP 90 mmHg on 2 occasions after 20
weeks’ gestation; preeclampsia was defined by the same criteria with
proteinuria of 1 on dipstick testing occurring at the same time as
the elevated BP. This produced 4 mutually exclusive categories of no
HDP, gestational hypertension, preeclampsia, and essential hyper-
tension. Gestational age at delivery (in weeks) was calculated as the
difference between the delivery date and the mother’s reported last
menstrual period date or updated if ultrasound information was
available, which led to a reassessment of gestation. At the time of
recruitment, it was not routine clinical practice to perform ultrasound
gestational age dating in early pregnancy, and in the data abstracted
from the clinical records it was not recorded which few women had
a scan or had their gestational age adjusted.
Maternal age at delivery and offspring sex were abstracted from
obstetric records. Maternal height, prepregnancy weight, parity,
highest educational qualification, and smoking status were obtained
from questionnaires administered during early pregnancy. Prepreg-
nancy body mass index was calculated as weight (in kilograms)/
height (in meters) squared and categorized as underweight (18.5
kg/m2), normal (18.5–24.9 kg/m2), overweight (25.0–29.9kg/m2),
and obese (30.0 kg/m2). Smoking status was classed as “never” for
women who did not smoke immediately before or during pregnancy,
“prepregnancy/first trimester” for women who smoked only imme-
diately before pregnancy or in the first 3 months of gestation, or
“throughout” for women who continued to smoke after the first
trimester.
Statistical Analysis
We first developed linear spline random-effects models for SBP and
DBP changes across gestation, as described previously.11 To take
account of data clustering because of the multiple antenatal visits per
woman, multilevel modeling using antenatal visits (level 1) within
women (level 2) was used. We randomly sampled 1 measurement
per 2-week period of gestation for each woman to prevent women
with many measurements from having too great an influence on the
models, leaving a median of 10 (interquartile range, 9–11) BP
measurements per woman. For both SBP and DBP, the best-fitting
models had knot points (indicating changes in the slope) at 18, 30,
and 36 weeks’ gestation, and baseline was set at 8 weeks’ gestation,
because there were few measurements before this. This produced 5
individual-level random-effects parameters, SBP/DBP at 8 weeks
and SBP/DBP change 8 to 18 weeks, 18 to 30 weeks, 30 to 36 weeks,
and 36 weeks onward.
Because women who have a greater rise in BP in late gestation are
likely to deliver earlier, to have fewer BP measurements over
pregnancy, and, therefore, to have less influence in statistical models,
the overall average increase in BP in the population would be
underestimated by these univariate models. This problem could not
be overcome by simply conditioning on gestational age at delivery in
our analysis, because, if length of gestation is influenced by both BP
change and HDP, this would bias our estimate of the association
between BP change and HDP (see Figure S1, available in the
online-only Data Supplement).27 We, therefore, combined the
random-effects spline models for BP with a model for time to
delivery to produce a joint model with SBP (or DBP) and time to
delivery as outcome variables to adjust for this. Please see the
online-only Data Supplement for further information. We included
HDP category as a covariate, with normotensive pregnancies as the
reference, and adjusted for maternal prepregnancy body mass index,
maternal age, parity, smoking, education, and offspring sex (for
singleton pregnancies) or twin pregnancy by including these as
covariates also. We assessed whether the relationships of maternal
characteristics with BP changes across pregnancy differed between
HDP categories by testing for interactions between each of the
maternal covariates and HDP category.
The correlations between BP changes and time to delivery were
derived from the random effects for BP outcomes and the residual error
from the time to delivery model (please see the online-only Data
Supplement). Model 1 was adjusted for HDP category and maternal
covariates. In model 2 we also adjusted for SBP/DBP at 8 weeks’
gestation and SBP/DBP change in earlier periods of pregnancy.
To examine whether secondary causes of hypertension or the use
of antihypertensive medication affected our results, we repeated
analyses excluding 442 women who reported ever having had kidney
disease, 41 essential hypertensive women who reported using med-
ication to treat their hypertension, and 59 women who reported using
antihypertensives, -blockers, or calcium channel blockers (for any
reason) regularly, or at any time, during their pregnancy (total
excluded, 519). We also completed sensitivity analyses restricting to
women who contributed 9 BP measurements to the spline models
(N7940) and to women with 11 measurements (N7465).
Statistical analyses were carried out using MLwiN version 2.23 and
Stata version 11.2 combined with runmlwin.28
Results
The characteristics of the full cohort and the subset of women
who had complete data on all maternal covariates are shown
in Table 1 and by HDP category in Table S1. The distribu-
tions of each of the variables were similar in the full data set
and the subset with complete data. In total, 80.0%
(N10419) of women were normotensive throughout preg-
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nancy, 14.6% (N1896) developed gestational hypertension,
2.1% (N277) developed preeclampsia, and 3.3% (N424)
had essential hypertension. The numbers of women who devel-
oped gestational hypertension and preeclampsia at different
gestational ages are shown in Table S2. Both of these conditions
most commonly developed between 35 and 39 weeks’ gestation.
Average BP levels at baseline and average changes in BP per
week from univariate models are shown in Table S3.
Gestational age at delivery ranged from 24 to 44 weeks.
Women who had essential hypertension or developed pre-
eclampsia had a shorter average gestational period than
normotensive women (Table S4).
Associations of BP Change With HDP
The Figure shows the average patterns of BP change across
pregnancy by HDP category in the joint models. SBP and
DBP were notably higher throughout pregnancy for women
who had any of essential hypertension, gestational hyperten-
sion, or preeclampsia compared with normotensive women.
Women who developed gestational hypertension had similar
DBP until 18 weeks’ gestation and SBP until 30
weeks’ gestation to women who developed preeclampsia,
after which BP increases were greater in women who
developed preeclampsia compared with those who devel-
oped gestational hypertension. Women who had essential
hypertension had the highest SBP and DBP at 8 weeks but
similar SBP and DBP in late pregnancy to women who
developed gestational hypertension.
The mean differences in SBP at 8 weeks and change in
SBP in each period of pregnancy associated with gestational
hypertension, preeclampsia, and essential hypertension com-
pared with no HDP are shown in Table 2. The equivalent
associations for DBP are shown in Table 3. In both unad-
justed and adjusted models, gestational hypertension (com-
pared with women remaining normotensive) was associated
with a higher SBP and DBP at 8 weeks, a smaller decrease in
SBP between 8 and 18 weeks, and a greater increase in SBP
and DBP between 18 and 30 weeks, between 30 and 36
weeks, and after 36 weeks. Preeclampsia (compared with
women remaining normotensive) was also associated with a
higher SBP and DBP at 8 weeks and with a greater increase
in SBP and DBP between 18 and 30 weeks, 30 and 36 weeks,
and after 36 weeks. Essential hypertension (compared with
women remaining normotensive) was associated with a
higher SBP and DBP at 8 weeks, a greater increase in DBP
between 30 and 36 weeks’ gestation, and a greater increase in
SBP and DBP after 36 weeks.
Women who had essential hypertension had higher SBP
and DBP at 8 weeks than women who developed gestational
hypertension or preeclampsia (all P0.05), but there was
little difference in SBP or DBP at 8 weeks between women
who developed gestational hypertension or preeclampsia.
Those who developed preeclampsia had a greater increase in
DBP between 18 and 30 weeks and in SBP and DBP between
30 and 36 weeks and after 36 weeks than women who
developed gestational hypertension or had essential hyperten-
sion (all P0.07). Women who developed gestational hyper-
tension had a greater rise in SBP and DBP between 18 and 30
weeks and in DBP from 36 weeks onward than those with
essential hypertension (all P0.01) but similar rates of BP
change in other periods.
Figures S2 through S13 show the patterns of SBP and DBP
changes across pregnancy by each of the maternal risk factors
and HDP status, derived from a model including interactions
of each of the maternal risk factors with HDP and SBP/DBP
at 8 weeks and also with HDP and each of the splines for
SBP/DBP change. These figures show that the patterns of
association of each of the maternal characteristics with BP
changes are similar in each HDP group.
Associations of BP Change With Time to Delivery
Table 4 shows the associations of BP at 8 weeks and changes
in BP with time to delivery. Neither SBP or DBP at 8 weeks
Table 1. Characteristics of the Full Data Set and Women
Who Had Complete Data on All of the Covariables
Maternal Characteristic
Full Data Set
(Total N13 016)
Complete Data
on All Variables
(N9930)
Gestational age at delivery, wk N13,016
Median (IQR) 40 (39–41) 40 (39–41)
HDP, % N13 016
No HDP 80.05 80.26
Gestational hypertension 14.57 14.26
Preeclampsia 2.13 1.95
Essential hypertension 3.26 3.52
Maternal prepregnancy BMI, % N10 839
Underweight 5.08 4.91
Normal 74.29 74.65
Overweight 15.04 14.94
Obese 5.59 5.49
Maternal age (y), % N13 016
20 4.86 3.41
20–24 19.48 16.73
25–29 38.60 39.60
30–34 27.29 29.68
35 9.78 10.58
Parity, % N12 097
Nulliparous 45.07 45.32
Multiparous 54.93 54.68
Smoking, % N12 208
Never 66.52 69.19
Prepregnancy/first trimester 13.78 13.14
Throughout 19.70 17.66
Education, % N11 674
CSE/vocational 30.00 27.64
O level 34.65 35.37
A level 22.42 23.33
Degree 12.93 13.66
Pregnancy type, % N13 016
Male singleton 50.81 50.51
Female singleton 47.87 48.20
Twin 1.32 1.29
BMI indicates body mass index; CSE, certificate of secondary education;
HDP, hypertensive disorder of pregnancy; IQR, interquartile range.
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nor change in SBP or DBP 18 weeks was associated with
the length of gestation in any models. However, a greater rise
in DBP between 18 and 30 weeks and in SBP or DBP
between 30 and 36 weeks or from 36 weeks onward was
associated with a shorter gestational period in models ad-
justed only for HDP category and maternal covariates (model
1). These associations were stronger when adjusting for
baseline BP and previous BP changes (model 2). The pre-
dicted lengths of gestation at 2 SDs above and below the
average BP at 8 weeks and changes in BP in each period of
gestation are shown in Table S5. When we restricted analyses
with length of gestation as the outcome to women who
remained normotensive throughout pregnancy (N7970),
most findings were unchanged, except that SBP and DBP
changes from 36 weeks onward were associated with length
of gestation only in model 2.
None of the findings were meaningfully changed when we
excluded women who reported having kidney disease or
taking antihypertensive medication or women with 9 mea-
surements (full results of these sensitivity analyses are avail-
able from authors). When women who had 11 measure-
ments were excluded, findings were similar, except that SBP
change between 8 and 18 weeks did not differ between
gestational hypertensive and normotensive pregnancies as in
the main analysis (adjusted mean difference [95% CI] in SBP
change for gestational hypertensive compared with normo-
11
0
12
0
13
0
14
0
15
0
Sy
st
ol
ic
 b
lo
od
 p
re
ss
ur
e 
(m
m
 H
g)
10 20 30 40
Gestational age (weeks)
Systolic blood pressure
60
70
80
90
10
0
10 20 30 40
Diastolic blood pressure
D
ia
st
ol
ic
 b
lo
od
 p
re
ss
ur
e 
(m
m
 H
g)
Gestational age (weeks)
gestational hypertensionno HDP
preeclampsia
95% confidence interval
essential hypertension
A
B
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tensive pregnancies: 0.028 mmHg per week [0.162 to
0.106 mmHg per week]). This may be because of the later
enrolment time of women who had 11 measurements
(median, 12.3 weeks’ compared with 9.7 weeks’ gestation for
women with 11 measurements) or may suggest that this
early pregnancy difference is only apparent in women who
develop more severe gestational hypertension.
Discussion
In this large prospective cohort of women, we have shown
that women who developed gestational hypertension or pre-
eclampsia had higher BP from very early in pregnancy, a
reduced initial decline in SBP to 18 weeks’ gestation, and a
faster increase in BP from 18 weeks onward and then, in
those destined to develop preeclampsia, a further marked
increase in BP from 30 weeks. We also found that women
who had essential hypertension had higher BP than all of the
other groups in early pregnancy and a greater rise in BP than
normotensive women in late pregnancy but showed a similar
early pregnancy decline in BP to normotensive women.
Of note, BP levels at baseline (8 weeks), although much
higher than for women who remained normotensive, were
very similar in both preeclamptic women and those with
gestational hypertension. This is despite some evidence that
the latter 2 conditions are different from each other, with
preeclampsia generally considered a 2-stage syndrome, the
first stage being poor placentation and the second being
maternal manifestation of hypertension and proteinuria later
in pregnancy,29 whereas gestational hypertension has been
described as latent hypertension revealed by pregnancy.30
Table 2. Mean Difference (95% CI) in SBP at 8 wk and Change in SBP in Each Period of Gestation by Hypertensive Disorders
of Pregnancy (N9930)
Maternal Characteristics
Mean Difference in
SBP at 8 wk, mm Hg
Mean Difference in Average SBP Change, mm Hg/wk
8–18 wk 18–30 wk 30–36 wk 36 wk
Unadjusted model
No HDP 0 0 0 0 0
Gestational hypertension 8.189 (7.373–9.005) 0.137 (0.039–0.234) 0.148 (0.089–0.207) 0.330 (0.213–0.447) 0.707 (0.516–0.897)
Preeclampsia 7.528 (5.541–9.515) 0.117 (0.120 to 0.355) 0.090 (0.060 to 0.240) 1.475 (1.167–1.783) 2.418 (1.818–3.018)
Essential hypertension 11.046 (9.530–12.562) 0.011 (0.192 to 0.171) 0.005 (0.108 to 0.117) 0.171 (0.054 to 0.397) 0.397 (0.017–0.777)
Adjusted model
No HDP 0 0 0 0 0
Gestational hypertension 7.151 (6.325–7.978) 0.107 (0.007–0.207) 0.183 (0.122–0.243) 0.330 (0.211–0.450) 0.744 (0.549–0.940)
Preeclampsia 6.513 (4.533–8.493) 0.072 (0.167 to 0.311) 0.129 (0.021 to 0.280) 1.463 (1.154–1.772) 2.409 (1.808–3.011)
Essential hypertension 9.900 (8.389–11.411) 0.029 (0.211 to 0.154) 0.043 (0.069 to 0.156) 0.182 (0.045 to 0.409) 0.454 (0.072–0.836)
Both models are adjusted for time to delivery; adjusted model is additionally adjusted for maternal prepregnancy BMI, age, parity, smoking during pregnancy,
education, and sex/No. of fetuses. In reference category (normotensive women), for unadjusted model, mean SBP at 8 wk (mm Hg)  111.011; mean SBP change
(mm Hg/wk): 8–18 wk  0.164; 18–30 wk0.137; 30–36 wk0.196; 36 wk1.054. For adjusted model, mean SBP at 8 wk (mm Hg)  111.966; mean SBP
change (mm Hg/wk): 8–18 wk  0.188; 18–30 wk0.150; 30–36 wk0.134; 36 weeks1.222. BMI indicates body mass index; HDP, hypertensive disorder
of pregnancy; SBP, systolic blood pressure.
Table 3. Mean Difference (95% CI) in DBP at 8 wk and Change in DBP in Each Period of Gestation by Hypertensive Disorders
of Pregnancy (N9930)
Maternal Characteristics
Mean Difference in
DBP at 8 wk, mm Hg
Mean Difference in Average DBP Change, mm Hg/wk
8–18 wk 18–30 wk 30–36 wk 36 wk
Unadjusted model
No HDP 0 0 0 0 0
Gestational hypertension 4.692 (4.09–5.287) 0.044 (0.027 to 0.115) 0.113 (0.069–0.156) 0.401 (0.311–0.491) 0.805 (0.655–0.954)
Preeclampsia 5.470 (4.020–6.920) 0.007 (0.180 to 0.166) 0.220 (0.110–0.331) 1.406 (1.170–1.642) 2.486 (2.017–2.956)
Essential hypertension 7.562 (6.455–8.668) 0.061 (0.072 to 0.193) 0.055 (0.137 to 0.028) 0.329 (0.156–0.502) 0.274 (0.023 to 0.572)
Adjusted model
No HDP 0 0 0 0 0
Gestational hypertension 3.799 (3.200–4.398) 0.038 (0.035 to 0.110) 0.132 (0.088–0.177) 0.370 (0.278–0.461) 0.833 (0.680–0.987)
Preeclampsia 4.674 (3.242–6.107) 0.028 (0.202 to 0.145) 0.239 (0.129–0.350) 1.336 (1.099–1.573) 2.465 (1.995–2.935)
Essential hypertension 6.585 (5.490–7.679) 0.056 (0.077 to 0.189) 0.029 (0.112 to 0.054) 0.312 (0.138–0.486) 0.333 (0.035–0.632)
Both models are adjusted for time to delivery; adjusted model is additionally adjusted for maternal prepregnancy BMI, age, parity, smoking during pregnancy,
education, and sex/No. of fetuses. In reference category (normotensive women), for unadjusted model, mean DBP at 8 wk (mm Hg)  65.393; mean DBP change
(mm Hg/wk): 8–18 wk  0.202; 18–30 wk0.091; 30–36 wk0.375; 36 wk1.155. For adjusted model, mean DBP at 8 wk (mm Hg)  65.494; mean DBP
change (mm Hg/wk): 8–18 wk  0.175; 18–30 wk0.109; 30–36 wk0.463; 36 wk1.252. BMI indicates body mass index; DBP, diastolic blood pressure;
HDP, hypertensive disorder of pregnancy.
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There is, however, evidence that gestational hypertension and
preeclampsia share many risk factors,31–33 suggesting that
there are common mechanisms behind the development of
both of these disorders. In addition, women who develop
either gestational hypertension or preeclampsia have simi-
larly increased risk of cardiovascular disease in later life.34,35
Although preeclampsia generally carries a greater risk of
intrauterine growth restriction and preterm birth than gesta-
tional hypertension,31,33 women who have severe gestational
hypertension have greater risk than those with mild pre-
eclampsia.4 Thus, our results are consistent with other evi-
dence suggesting that there is important overlap between
these 2 conditions.
Our finding that BP and, in particular, DBP rose more
steeply from 18 weeks’ gestation onward in women who
developed preeclampsia compared with those who developed
gestational hypertension or had essential hypertension is
striking. Previous analyses of rhythm-adjusted mean BP in
202 women at risk of HDP also demonstrated equivalent BP
in early pregnancy and then later discordance, with higher BP
in preeclampsia than gestational hypertension.21 However a
study using clinic BP measurements (N8000) found that
women who developed preeclampsia had lower BP in the first
trimester than women who developed gestational hyperten-
sion, which may be because of the slightly later timing of
measurement (median gestational age, 13.2 weeks) than our 8
weeks’ baseline. In agreement with our findings, they also
reported that preeclamptic women had a steeper rise in BP
across pregnancy compared with gestational hypertensive
women.22 Another study (N212) reported that women who
developed preeclampsia had higher rhythm-adjusted mean
BP in late pregnancy than women who had essential hyper-
tension or developed gestational hypertension.20 Our ob-
served early rise in BP in preeclampsia is consistent with
histological studies of impaired trophoblast invasion of myo-
metrial arterial segments and thereby a necessity to increase
baseline maternal placental perfusion,36 as evidenced by the
increase in DBP.
Given the similarities in risk factors between gestational
hypertension and preeclampsia, the discordance in BP trajec-
tory and presence of proteinuria, which would define pre-
eclampsia, may simply be reflecting the extent of impaired
placentation and an individual’s renal threshold for manifest-
ing proteinuria. Consistent with this, 50% of women who
manifest mild hypertension before 35 weeks’ gestation de-
velop preeclampsia later in pregnancy.29 Furthermore, even if
gestational hypertension and preeclampsia are influenced by
different biological mechanisms, then our results suggest that
equivalent levels of early pregnancy BP predispose to both
but that the biological changes related to preeclampsia pro-
duce more extreme increases in BP than those related to
gestational hypertension.
The relationship that we found between a greater rise in BP
after 18 weeks and a shorter time to delivery is in agreement
with the study by Zhang et al,37 which investigated BP
change in 8325 nulliparous women from 6 countries. They
found that women who had an early preterm birth (34
weeks) and those who had a late preterm birth (34–36 weeks)
had a greater rise in SBP and DBP between 12 to 19 weeks’
and 30 to 34 weeks’ gestation compared with women who
delivered at term. Associations with spontaneous preterm
birth were attenuated compared with those with all preterm
births but remained strong.37 We were unable to restrict to
spontaneous deliveries, because we did not have these data
available. However, we found that associations of DBP
change from 18 weeks onward and SBP change from 30
weeks onward with length of gestation remained strong when
restricting to women with normotensive pregnancies. The
mechanism underlying the relationship between BP change
and time to delivery is not clear, but the hypothalamic
pituitary adrenal axis regulates both BP and maternal cortisol
Table 4. Associations of Blood Pressure at 8 wk Gestation
and Changes in Blood Pressure in Each Period of Pregnancy
With the Time to Delivery (N9930)
Blood Pressure Variable
Length of Gestation
% Increase
in Gestation 95% CI
SBP at 8 wk, mm Hg
Model 1 0.00 (0.02, 0.02)
SBP change, mm Hg/wk
8–18 wk
Model 1 0.20 (0.63, 0.20)
Model 2 0.22 (0.65, 0.17)
18–30 wk
Model 1 0.28 (0.73, 0.15)
Model 2 0.47 (0.92,0.04)
30–36 wk
Model 1 0.91 (1.16,0.70)
Model 2 1.17 (1.43,0.95)
36 wk
Model 1 0.14 (0.26,0.01)
Model 2 0.54 (0.69,0.40)
DBP at 8 wk, mm Hg
Model 1 0.01 (0.02, 0.05)
DBP change, mm Hg/wk
8–18 wk
Model 1 0.51 (1.35, 0.19)
Model 2 0.55 (1.42, 0.18)
18–30 wk
Model 1 1.29 (2.10,0.62)
Model 2 1.66 (2.42,1.00)
30–36 wk
Model 1 1.33 (1.62,1.10)
Model 2 1.71 (2.03,1.46)
36 wk
Model 1 0.16 (0.29,0.03)
Model 2 0.65 (0.79,0.50)
Model 1 was adjusted for HDP, maternal prepregnancy BMI, age, parity,
smoking during pregnancy, education, and sex/No. of fetuses. Model 2 was
additionally adjusted for SBP/DBP at 8 wk and SBP/DBP change in earlier
periods of gestation. DBP indicates diastolic blood pressure; SBP, systolic blood
pressure; HDP, hypertensive disorder of pregnancy; BMI, body mass index.
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concentrations, which are negatively associated with gesta-
tional age at birth.38
The strengths of our study are its large size, many repeated
measurements of BP, which allowed HDP to be classified
accurately, and the ability to model BP change and time to
delivery in parallel. Limitations of our study include the use
of routinely collected clinic measurements of BP. These are
likely to be subject to a high degree of variability over the
course of the day and between observers, because the method
of measurement was not standardized between clinics. How-
ever, this reflects what is currently used in clinical practice to
detect gestational hypertension and preeclampsia, and, thus,
our results are applicable to this setting. We would not expect
this to introduce bias into our findings, only random mea-
surement error. More than 90% of women in this study
attended 1 of 2 hospitals, and when we repeated the analysis
for each of these separately, results were similar. Because
measurements of BP before pregnancy were unavailable, we
have used self-report of previous hypertension to classify
essential hypertension. The higher level of BP in early
pregnancy, which we found in this group compared with all
of the other HDP groups, does, however, support this self-
report. Although we have named this group essential hyper-
tensives, this is likely to include a small number of women
who had secondary hypertension, because we did not have
information on all secondary causes. We were unable to
distinguish between medically indicated induced and sponta-
neous deliveries; we have attempted to eliminate medically
indicated deliveries related to high BP by repeating analyses
in normotensive women but cannot exclude induced deliver-
ies that were related to other conditions.
Perspectives
Our findings suggest that, as well as early pregnancy BP, the
rate of increase in BP after 18 weeks may provide an early
indication of those women most at risk of developing gesta-
tional hypertension or preeclampsia before the BP threshold
used for diagnosis of HDP is crossed. Furthermore, women
who developed gestational hypertension had a smaller de-
crease in SBP 18 weeks, compared with normotensive
women, meaning that careful planned monitoring of BP
change in those with high levels at their booking clinic may
help earlier identification of women at risk of developing
either gestational hypertension or preeclampsia.
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Description of joint models for blood pressure change and time to delivery 
 
We aimed to model blood pressure change jointly with time to delivery, using a joint model 
as described by Touloumi et al.(1) However, since gestational age at birth had a left-skewed 
distribution, which was difficult to model in this way, we reversed this variable to the number 
of weeks preterm, and centred this variable so that all values were greater than zero (this 
variable was calculated as 45 – gestational age in weeks, as the maximum length of gestation 
was 44 weeks). This variable therefore had a right-skewed distribution, which enabled us to 
use a lognormal model for this outcome. Covariates were included in the blood pressure 
change part of the models as a main effect and an interaction with each of the splines, and 
also in the time to delivery model as a main effect. 
 
To regress time to delivery on blood pressure at baseline and blood pressure changes in each 
period of pregnancy we used the variances and pairwise covariances of the residual error 
from the time to delivery model and the individual-level random effects for blood pressure at 
8 weeks and blood pressure change in each of the periods of gestation. Formulae described by 
Fisher were used to derive regression coefficients and standard errors from these variances 
and covariances.(2) In order to fully incorporate the uncertainty in the estimation of the 
variances and covariances of random effects and residuals we generated 10,000 realisations 
of the parameter estimates from the joint model, from a multivariate normal distribution using 
the means, variances and covariances of these estimates, and calculated regression 
coefficients for each of these realisations. Although the reverse of time to delivery was 
modelled, we transformed the regression coefficients to calculate the percentage difference in 
length of gestation associated with a unit increase in each of the blood pressure variables. 
These percentage differences were averaged over the 10,000 realisations, and 95% 
confidence intervals were formed using the 2.5th and 97.5th percentiles of the distributions of 
these values to fully incorporate the uncertainty in the estimation procedure. We therefore 
present the percentage mean increase in gestation per mmHg increase in SBP/DBP at 8 weeks 
or mmHg/week increase in rate of change in SBP/DBP, so that a greater coefficient 
represents a longer gestational period. 
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Supplemental Tables and Figures 
Table S1 Characteristics of the full dataset and women who had complete data on all covariables by hypertensive disorders of pregnancy 
Maternal 
Characteristic 
Full dataset (Total N=13,016) Complete data on all variables (N=9,930) 
Normotensive 
  
(N = 10,419) 
Gestational 
Hypertension 
(N = 1,896) 
Preeclampsia 
  
(N = 277) 
Essential 
Hypertension
(N = 424) 
Normotensive 
 
(N = 7,970) 
Gestational 
Hypertension 
(N = 1,416) 
Preeclampsia 
  
(N=194) 
Essential  
Hypertension 
(N = 350) 
Gestational age at 
delivery (weeks) 
median (IQR) 
 
N=10,419 
40 (39, 41) 
 
N=1,896 
40 (39, 41) 
 
N=277 
39 (36, 40) 
 
N=424 
40 (38, 40) 
 
 
40 (39, 41) 
 
 
40 (39, 41) 
 
 
39 (37, 40) 
 
 
40 (38, 40) 
Maternal pre-
pregnancy BMI (%) 
Underweight 
Normal 
Overweight 
Obese 
 
N=8,681 
5.71 
77.13 
13.39 
3.77 
 
N=1,551 
2.13 
62.22 
23.08 
12.57 
 
N=220 
3.64 
65.91 
17.73 
12.73 
 
N=387 
3.62 
63.57 
18.35 
14.47 
 
 
5.51 
77.48 
13.35 
3.66 
 
 
2.12 
62.85 
22.53 
12.50 
 
 
3.61 
63.92 
19.07 
13.40 
 
 
3.43 
64.00 
18.29 
14.29 
Age (yrs) (%) 
15-19 
20-24 
25-29 
30-34 
35+ 
N=10,419 
5.03 
19.02 
38.47 
28.05 
9.43 
N=1,896 
3.90 
21.84 
39.14 
24.63 
10.50 
 
N=277 
8.66 
25.99 
34.30 
18.77 
12.27 
N=424 
2.36 
15.80 
42.22 
25.94 
13.68 
 
3.64 
16.10 
39.37 
30.46 
10.43 
 
2.40 
19.42 
40.68 
26.91 
10.59 
 
5.15 
27.32 
35.05 
21.13 
11.34 
 
1.43 
14.29 
42.86 
27.71 
13.71 
Parity (%) 
Nulliparous 
Multiparous 
N=9,684 
42.14 
57.86 
N=1,761 
55.99 
44.01 
N=248 
69.35 
30.65 
N=404 
52.72 
47.28 
 
42.27 
57.73 
 
56.64 
43.36 
 
73.71 
26.29 
 
53.14 
46.86 
Smoking in 
pregnancy (%) 
Never 
Pre-pregnancy/1st 
trimester 
Throughout  
 
N=9,776 
65.41 
13.61 
 
20.98 
 
N=1,773 
69.66 
14.95 
 
15.40 
 
N=249 
75.10 
15.66 
 
9.24 
 
N=410 
74.39 
11.46 
 
14.15 
 
 
68.19 
13.05 
 
18.76 
 
 
72.46 
13.77 
 
13.77 
 
 
74.74 
17.01 
 
8.25 
 
 
75.71 
10.57 
 
13.71 
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Education (%) 
CSE/Vocational 
O Level 
A Level 
Degree 
N=9,324 
30.41 
33.92 
22.75 
12.92 
N=1,711 
29.22 
36.53 
21.10 
13.15 
N=237 
28.69 
37.13 
23.21 
10.97 
N=402 
24.63 
42.04 
19.90 
13.43 
 
28.04 
34.55 
23.76 
13.64 
 
26.91 
37.43 
21.68 
13.98 
 
27.32 
38.14 
23.71 
10.82 
 
21.71 
44.00 
20.00 
14.29 
Pregnancy type (%) 
Male singleton 
Female singleton 
Twin 
N=10,419 
50.60 
48.24 
1.16 
N=1,896 
51.74 
46.04 
2.22 
N=277 
49.10 
48.01 
2.89 
N=424 
52.83 
46.93 
0.24 
 
50.29 
48.57 
1.14 
 
51.48 
46.33 
2.19 
 
47.42 
49.48 
3.09 
 
53.43 
46.57 
0.00 
 
Abbreviations: BMI body mass index; CSE certificate of secondary education; IQR interquartile range
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Table S2 Frequency distribution of the timing of onset of gestational hypertension and 
preeclampsia for women who developed these conditions 
Hypertensive disorder of 
pregnancy (HDP) 
Number of weeks of gestation at which HDP developed 
< 30 weeks 30-34 weeks 35-39 weeks ≥ 40 weeks 
Gestational hypertension 
N (%) 
 
29 (12.1) 
 
355 (18.7) 
 
948 (50.0) 
 
364 (19.2) 
Preeclampsia  
N (%) 
 
20 (7.2) 
 
36 (13.0) 
 
175 (63.2) 
 
46 (16.6) 
 
Abbreviations: HDP hypertensive disorder of pregnancy
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Table S3 Average blood pressure levels at baseline and average changes in blood 
pressure per week in each period of gestation from univariate linear spline random 
effects models (N=13,016) 
Blood pressure variable Mean Between-individual 
standard deviation 
95% reference 
range 
SBP at 8 weeks (mmHg) 
SBP change (mmHg/wk): 
8-18 weeks 
18-29 weeks 
29-36 weeks 
36+ weeks 
 
DBP at 8 weeks (mmHg) 
DBP change (mmHg/wk): 
8-18 weeks 
18-29 weeks 
29-36 weeks 
36+ weeks 
112.78  
 
-0.156 
0.166 
0.291 
1.075 
 
66.49  
 
-0.199 
0.112 
0.478 
1.207 
8.66 
 
0.575 
0.452 
0.955 
1.535 
 
6.00 
 
0.378 
0.331 
0.818 
1.351 
(95.80, 129.75) 
 
(-1.284, 0.972) 
(-0.721, 1.052) 
(-1.582, 2.164) 
(-1.933, 4.083) 
 
(54.72, 78.26) 
 
(-0.941, 0.542) 
(-0.537, 0.762) 
(-1.126, 2.082) 
(-1.440, 3.855) 
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Table S4 Associations of hypertensive disorders of pregnancy and maternal 
characteristics with time to delivery (N = 9,930) 
Characteristic Length of gestation 
% increase in gestation  95% confidence interval 
HDP group 
Normotensive 
Gestational hypertension 
Preeclampsia 
Essential hypertension 
 
0 
0.15 
-3.27 
-0.69 
 
- 
(-0.07, 0.37) 
(-3.96, -2.57) 
(-1.13, -0.25) 
Pre-pregnancy BMI 
Underweight 
Normal  
Overweight 
Obese 
 
-0.69 
0 
0.30 
0.22 
 
(-1.06, -0.31) 
- 
(0.09, 0.52) 
(-0.12, 0.56) 
Maternal Age (years) 
<20  
20-24  
25-29  
30-34  
35+  
 
0.09 
-0.04 
0 
-0.11 
-0.18 
 
(-0.35, 0.54) 
(-0.27, 0.19) 
- 
(-0.30, 0.08) 
(-0.46, 0.09) 
Parity 
Nulliparous 
Multiparous 
 
0 
-0.09 
 
- 
(-0.26, 0.07) 
Smoking 
Never 
Pre-pregnancy/1st trimester 
Throughout pregnancy 
 
0 
0.29 
-0.14 
 
- 
(0.06, 0.52) 
(-0.35, 0.07) 
Maternal education 
CSE/vocational 
O level 
A level 
Degree 
 
-0.13 
0 
-0.11 
0.29 
 
(-0.33, 0.06) 
- 
(-0.32, 0.09) 
(0.04, 0.54) 
Pregnancy type 
Male singleton 
Female singleton 
Twin 
 
0 
0.34 
-6.92 
 
- 
(0.19, 0.50) 
(-7.96, -5.88) 
 
Abbreviations: BMI body mass index; CSE certificate of secondary education; HDP 
hypertensive disorder of pregnancy
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Table S5 Average length of gestation by standard deviations of blood pressure at 8 weeks 
gestation and change in blood pressure in each period of pregnancy in the joint model 
adjusted for maternal covariates* 
Blood pressure variable Length of gestation (weeks) 
Average length 
of gestation 
95% confidence 
interval 
Average SBP and DBP at 8 weeks and average 
change in SBP and DBP in each period of gestation 
39.76 (39.67, 39.84) 
SBP at 8 weeks (1 SD = 7.51 mm Hg) 
+ 2 SD 
- 2 SD 
 
39.77 
39.74 
 
(39.63, 39.92) 
(39.59, 39.88) 
SBP change 8-18 weeks (1 SD = 0.58 mm Hg/week) 
+ 2 SD 
- 2 SD 
 
39.67 
39.85 
 
(39.46, 39.87) 
(39.65, 40.05) 
SBP change 18-30 weeks (1 SD = 0.44 mm Hg/week) 
+ 2 SD 
- 2 SD 
 
39.66 
39.85 
 
(39.49, 39.83) 
(39.69, 40.02) 
SBP change 30-36 weeks (1 SD = 0.93 mm Hg/week) 
+ 2 SD 
- 2 SD 
 
39.06 
40.37 
 
(39.88, 39.25) 
(40.23, 40.52) 
SBP change 36+ weeks (1 SD = 1.47 mm Hg/week) 
+ 2 SD 
- 2 SD 
 
39.60 
39.91 
 
(39.43, 39.77) 
(39.75, 40.07) 
DBP at 8 weeks (1 SD = 5.17 mm Hg) 
+ 2 SD 
- 2 SD 
 
39.82  
39.70 
 
(39.67, 39.97) 
(39.54, 39.85) 
DBP change 8-18 weeks (1 SD = 0.38 mm Hg/week) 
+ 2 SD 
- 2 SD 
 
39.61 
39.90 
 
(39.37, 39.84) 
(39.69, 40.12) 
DBP change 18-30 weeks (1 SD = 0.31 mm Hg/week) 
+ 2 SD 
- 2 SD 
 
39.44 
40.05 
 
(39.26, 39.63) 
(39.89, 40.22) 
DBP change 30-36 weeks (1 SD = 0.78 mm Hg/week) 
+ 2 SD 
- 2 SD 
 
38.90 
40.49 
 
(38.72, 39.08) 
(40.36, 40.62) 
DBP change 36+ weeks (1 SD = 1.28 mm Hg/week) 
+ 2 SD 
- 2 SD 
 
39.59 
39.92 
 
(39.43, 39.75) 
(39.77, 40.07) 
 
* Predictions are for women in the reference category: normotensive, normal pre-pregnancy weight, 
25-29 years of age, nulliparous, never smoked in pregnancy, O level education and male singleton 
pregnancy and for average levels of each of the blood pressure variables other than that being 
varied. 
Abbreviations: DBP diastolic blood pressure; SBP systolic blood pressure; SD standard deviation
 at University of Glasgow Library on January 9, 2013http://hyper.ahajournals.org/Downloaded from 
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Figure S1 Hypothesised relationships between blood pressure change, hypertensive disorders 
of pregnancy and length of gestation* 
 
 
 
 
 
 
 
 
*Arrows represent causal relationships; dashed lines represent an association. U is an unmeasured 
variable representing the underlying HDP, which is hypothesised to influence changes in blood 
pressure and the observed symptoms of HDP. Conditioning on length of gestation would bias the 
estimate of the association between blood pressure change and manifested HDP. 
Abbreviations: HDP hypertensive disorder of pregnancy
Manifestation of 
HDP 
Blood pressure change Length of gestation 
U 
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Figure S2 Predicted trajectories of systolic blood pressure across pregnancy by maternal pre-pregnancy BMI and hypertensive disorders of 
pregnancy (N=9,930)* 
1
1
0
1
2
0
1
3
0
1
4
0
1
5
0
1
6
0
S
y
s
t
o
l
i
c
 
b
l
o
o
d
 
p
r
e
s
s
u
r
e
 
(
m
m
 
H
g
)
10 20 30 40
Gestational age (weeks)
 underweight  normal weight
 overweight  obese
No HDP
1
1
0
1
2
0
1
3
0
1
4
0
1
5
0
1
6
0
S
y
s
t
o
l
i
c
 
b
l
o
o
d
 
p
r
e
s
s
u
r
e
 
(
m
m
 
H
g
)
10 20 30 40
Gestational age (weeks)
 underweight  normal weight
 overweight  obese
Gestational hypertension
1
1
0
1
2
0
1
3
0
1
4
0
1
5
0
1
6
0
S
y
s
t
o
l
i
c
 
b
l
o
o
d
 
p
r
e
s
s
u
r
e
 
(
m
m
 
H
g
)
10 20 30 40
Gestational age (weeks)
 underweight  normal weight
 overweight  obese
Pre-eclampsia
1
1
0
1
2
0
1
3
0
1
4
0
1
5
0
1
6
0
S
y
s
t
o
l
i
c
 
b
l
o
o
d
 
p
r
e
s
s
u
r
e
 
(
m
m
 
H
g
)
10 20 30 40
Gestational age (weeks)
 underweight  normal weight
 overweight  obese
Essential hypertension
 
* Trajectories are predicted by the fully-adjusted joint model including interactions of each of the maternal covariates with hypertensive disorder of 
pregnancy group and with blood pressure at baseline and blood pressure change in each period of gestation. 
Overall P for interaction = 0.019; 
P for interaction with: SBP at 8 weeks = 0.386; SBP change 8-18 weeks = 0.149; 18-30 weeks = 0.301; 30-36 weeks = 0.755; 36+ weeks = 0.306
 at U
niversity of G
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Figure S3 Predicted trajectories of systolic blood pressure across pregnancy by maternal age and hypertensive disorders of pregnancy 
(N=9,930)* 
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* Trajectories are predicted by the fully-adjusted joint model including interactions of each of the maternal covariates with hypertensive disorder of 
pregnancy group and with blood pressure at baseline and blood pressure change in each period of gestation. 
Overall P for interaction = 0.068; 
P for interaction with: SBP at 8 weeks = 0.202; SBP change 8-18 weeks = 0.684; 18-30 weeks = 0.770; 30-36 weeks = 0.596; 36+ weeks = 0.584
 at U
niversity of G
lasgow
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http://hyper.ahajournals.org/
D
ow
nloaded from
 
12 
 
Figure S4 Predicted trajectories of systolic blood pressure across pregnancy by parity and hypertensive disorders of pregnancy (N=9,930)* 
1
1
0
1
2
0
1
3
0
1
4
0
1
5
0
1
6
0
S
y
s
t
o
l
i
c
 
b
l
o
o
d
 
p
r
e
s
s
u
r
e
 
(
m
m
 
H
g
)
10 20 30 40
Gestational age (weeks)
 nulliparous  multiparous
No HDP
1
1
0
1
2
0
1
3
0
1
4
0
1
5
0
1
6
0
S
y
s
t
o
l
i
c
 
b
l
o
o
d
 
p
r
e
s
s
u
r
e
 
(
m
m
 
H
g
)
10 20 30 40
Gestational age (weeks)
 nulliparous  multiparous
Gestational hypertension
1
1
0
1
2
0
1
3
0
1
4
0
1
5
0
1
6
0
S
y
s
t
o
l
i
c
 
b
l
o
o
d
 
p
r
e
s
s
u
r
e
 
(
m
m
 
H
g
)
10 20 30 40
Gestational age (weeks)
 nulliparous  multiparous
Pre-eclampsia
1
1
0
1
2
0
1
3
0
1
4
0
1
5
0
1
6
0
S
y
s
t
o
l
i
c
 
b
l
o
o
d
 
p
r
e
s
s
u
r
e
 
(
m
m
 
H
g
)
10 20 30 40
Gestational age (weeks)
 nulliparous  multiparous
Essential hypertension
 
* Trajectories are predicted by the fully-adjusted joint model including interactions of each of the maternal covariates with hypertensive disorder of 
pregnancy group and with blood pressure at baseline and blood pressure change in each period of gestation. 
Overall P for interaction < 0.001; 
P for interaction with: SBP at 8 weeks = 0.012; SBP change 8-18 weeks = 0.387; 18-30 weeks = 0.435; 30-36 weeks = 0.029; 36+ weeks = 0.069
 at U
niversity of G
lasgow
 Library on January 9, 2013
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Figure S5 Predicted trajectories of systolic blood pressure across pregnancy by smoking during pregnancy and hypertensive disorders of 
pregnancy (N=9,930)* 
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* Trajectories are predicted by the fully-adjusted joint model including interactions of each of the maternal covariates with hypertensive disorder of 
pregnancy group and with blood pressure at baseline and blood pressure change in each period of gestation. 
Overall P for interaction = 0.272; 
P for interaction with: SBP at 8 weeks = 0.689; SBP change 8-18 weeks = 0.657; 18-30 weeks = 0.131; 30-36 weeks = 0.858; 36+ weeks = 0.182
 at U
niversity of G
lasgow
 Library on January 9, 2013
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Figure S6 Predicted trajectories of systolic blood pressure across pregnancy by maternal education and hypertensive disorders of pregnancy 
(N=9,930)* 
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* Trajectories are predicted by the fully-adjusted joint model including interactions of each of the maternal covariates with hypertensive disorder of 
pregnancy group and with blood pressure at baseline and blood pressure change in each period of gestation. 
Overall P for interaction = 0.148; 
P for interaction with: SBP at 8 weeks = 0.429; SBP change 8-18 weeks = 0.862; 18-30 weeks = 0.328; 30-36 weeks = 0.564; 36+ weeks = 0.454
 at U
niversity of G
lasgow
 Library on January 9, 2013
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Figure S7 Predicted trajectories of systolic blood pressure across pregnancy by pregnancy type and hypertensive disorders of pregnancy 
(N=9,930)* 
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* Trajectories are predicted by the fully-adjusted joint model including interactions of each of the maternal covariates with hypertensive disorder of 
pregnancy group and with blood pressure at baseline and blood pressure change in each period of gestation. 
Overall P for interaction = 0.004; 
P for interaction with: SBP at 8 weeks = 0.011; SBP change 8-18 weeks = 0.847; 18-30 weeks = 0.384; 30-36 weeks = 0.169; 36+ weeks = 0.072
 at U
niversity of G
lasgow
 Library on January 9, 2013
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Figure S8 Predicted trajectories of diastolic blood pressure across pregnancy by maternal pre-pregnancy BMI and hypertensive disorders of 
pregnancy (N=9,930)* 
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* Trajectories are predicted by the fully-adjusted joint model including interactions of each of the maternal covariates with hypertensive disorder of 
pregnancy group and with blood pressure at baseline and blood pressure change in each period of gestation. 
Overall P for interaction < 0.001; 
P for interaction with: DBP at 8 weeks = 0.607; DBP change 8-18 weeks = 0.583; 18-30 weeks = 0.428; 30-36 weeks = 0.520; 36+ weeks = 0.007
 at U
niversity of G
lasgow
 Library on January 9, 2013
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Figure S9 Predicted trajectories of diastolic blood pressure across pregnancy by maternal age and hypertensive disorders of pregnancy 
(N=9,930)* 
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*Trajectories are predicted by the fully-adjusted joint model including interactions of each of the maternal covariates with hypertensive disorder of 
pregnancy group and with blood pressure at baseline and blood pressure change in each period of gestation. 
Overall P for interaction = 0.007; 
P for interaction with: DBP at 8 weeks = 0.255; DBP change 8-18 weeks = 0.149; 18-30 weeks = 0.395; 30-36 weeks = 0.696; 36+ weeks = 0.480
 at U
niversity of G
lasgow
 Library on January 9, 2013
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Figure S10 Predicted trajectories of diastolic blood pressure across pregnancy by parity and hypertensive disorders of pregnancy (N=9,930)* 
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*Trajectories are predicted by the fully-adjusted joint model including interactions of each of the maternal covariates with hypertensive disorder of 
pregnancy group and with blood pressure at baseline and blood pressure change in each period of gestation. 
Overall P for interaction < 0.001; 
P for interaction with: DBP at 8 weeks <0.001; DBP change 8-18 weeks = 0.005; 18-30 weeks = 0.386; 30-36 weeks = 0.007; 36+ weeks = 0.253
 at U
niversity of G
lasgow
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Figure S11 Predicted trajectories of diastolic blood pressure across pregnancy by smoking during pregnancy and hypertensive disorders of 
pregnancy (N=9,930)* 
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*Trajectories are predicted by the fully-adjusted joint model including interactions of each of the maternal covariates with hypertensive disorder of 
pregnancy group and with blood pressure at baseline and blood pressure change in each period of gestation. 
Overall P for interaction < 0.001; 
P for interaction with: DBP at 8 weeks = 0.462; DBP change 8-18 weeks = 0.772; 18-30 weeks = 0.295; 30-36 weeks = 0.117; 36+ weeks = 0.020
 at U
niversity of G
lasgow
 Library on January 9, 2013
http://hyper.ahajournals.org/
D
ow
nloaded from
 
20 
 
Figure S12 Predicted trajectories of diastolic blood pressure across pregnancy by maternal education and hypertensive disorders of pregnancy 
(N=9,930)* 
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*Trajectories are predicted by the fully-adjusted joint model including interactions of each of the maternal covariates with hypertensive disorder of 
pregnancy group and with blood pressure at baseline and blood pressure change in each period of gestation. 
Overall P for interaction = 0.042; 
P for interaction with: DBP at 8 weeks = 0.015; DBP change 8-18 weeks = 0.570; 18-30 weeks = 0.751; 30-36 weeks = 0.311; 36+ weeks = 0.129
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Figure S13 Predicted trajectories of diastolic blood pressure across pregnancy by pregnancy type and hypertensive disorders of pregnancy 
(N=9,930)* 
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*Trajectories are predicted by the fully-adjusted joint model including interactions of each of the maternal covariates with hypertensive disorder of 
pregnancy group and with blood pressure at baseline and blood pressure change in each period of gestation. 
Overall P for interaction < 0.001; 
P for interaction with: DBP at 8 weeks = 0.336; DBP change 8-18 weeks = 0.898; 18-30 weeks = 0.441; 30-36 weeks = 0.239; 36+ weeks = 0.175 
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